Brincidofovir

January 26, 2015
Image of Brincidofovir 3D Image of Brincidofovir

Remember Ebola? Its predominance in the news has diminished recently, but the need for developing drugs to combat ebolavirus infections is a strong as ever. Brincidofovir is an experimental drug under development by Chimerix (Durham, NC) for combating several viruses, including Ebola. Its activity against Ebola is somewhat unexpected because, unlike other viruses attacked by brincidofovir, Ebola is a single-stranded RNA virus, not a double-stranded DNA virus.

In December 2014, Doctors without Borders began clinical trials on brincidofovir in West Africa. Previously, two out of the three Ebola patients treated with the drug in the United States survived, but whether their survival can be attributed to it is not known.

Chemical Abstract Service - a division of ACS

Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.

Molecule of the Week needs your suggestions!

If your favorite molecule is not in our archive, please send an email to motw@acs.org. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!

Stay Ahead of the Chemistry Curve

Learn how ACS can help you stay ahead in the world of chemistry.